274 followers
RT @NK_papers: Optimization of Donor Lymphocyte Infusion for AML Relapse After Allo-HCT in the Era of New Drugs and Cell Engineering by Yis…
RT @NK_papers: Optimization of Donor Lymphocyte Infusion for AML Relapse After Allo-HCT in the Era of New Drugs and Cell Engineering by Yis…
Optimization of Donor Lymphocyte Infusion for AML Relapse After Allo-HCT in the Era of New Drugs and Cell Engineering by Yishan Ye https://t.co/dZggqYFLes
New research: Optimization of Donor Lymphocyte Infusion for AML Relapse After Allo-HCT in the Era of New Drugs and Cell Engineering: Donor lymphocyte infusion (DLI) is a key strategy for the treatment of AML relapse after allogeneic… https://t.co/8yJo1G6en